Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Options Insight: How to Play the SPDR S&P 500 ETF
31:59 - Dan Deming, KKM Financial's managing director, discusses the performance of stocks and his options strategy for the SPDR S&P 500 ETF with Bloomberg's Julie Hyman on "Bloomberg Markets." (Source: Bloomberg)
  • Full Show: Bloomberg ‹GO› (05/25)
  • Is the Fed Really Ready to Raise Interest Rates?
  • Brynjolfsson: Why the Oil Rally Will Falter